相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury
Ping Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2020)
The Thioredoxin System: A Promising Target for Cancer Drug Development
Hiba Ghareeb et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy
Mirna Jovanovic et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2019)
Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells
Luigi Minafra et al.
SCIENTIFIC REPORTS (2019)
Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT
Haiyan Zhu et al.
BMC CANCER (2019)
An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients
Alfonso Varela-Lopez et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Blood biomarkers for stroke: the role of thioredoxin in diagnosis and prognosis of acute ischemic stroke
Mohammed I. Oraby et al.
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2019)
Relevance of Half-Life in Drug Design
Dennis A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Le Tang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
J. A. Alberro et al.
LANCET ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting the Thioredoxin System for Cancer Therapy
Junmin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
Rachel W. Anantha et al.
ELIFE (2017)
TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport
Yushuo Zhang et al.
SCIENTIFIC REPORTS (2017)
Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway
Gang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Therapeutic drug monitoring of 5-fluorouracil
James J. Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines
Nesstor Pilco-Ferreto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC
Xiaojun Liu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
Samuel N. Rodman et al.
RADIATION RESEARCH (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
Prahlad V. Raninga et al.
ONCOTARGET (2015)
Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells
Yuan-Wei Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Biological Effect of Large Single Doses: A Possible Role for Non-Targeted Effects in Cell Inactivation
Marlon R. Veldwijk et al.
PLOS ONE (2014)
Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012
Michael B. Barton et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
Yimin Zhang et al.
ONCOTARGET (2014)
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Dler Faieeq Darweesh Mahmood et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
EO9 (Apaziquone): from the clinic to the laboratory and back again
Roger M. Phillips et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase
Chaoran Liu et al.
PLOS ONE (2013)
Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression
Markus Selenius et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Antitumor Indolequinones Induced Apoptosis in Human Pancreatic Cancer Cells via Inhibition of Thioredoxin Reductase and Activation of Redox Signaling
Chao Yan et al.
MOLECULAR PHARMACOLOGY (2012)
Motexafin gadolinium: a promising radiation sensitizer in brain metastasis
Sayana Rachel Thomas et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells
Antonietta R. Farina et al.
FEBS LETTERS (2011)
The Emerging Role of the Thioredoxin System in Angiogenesis
Louise L. Dunn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide
Jelena Kasapovic et al.
CLINICAL BIOCHEMISTRY (2010)
Focus on mammalian thioredoxin reductases - Important selenoproteins with versatile functions
Elias S. J. Arner
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
C. S. Pichot et al.
BRITISH JOURNAL OF CANCER (2009)
Potent Activity of Indolequinones against Human Pancreatic Cancer: Identification of Thioredoxin Reductase as a Potential Target
Chao Yan et al.
MOLECULAR PHARMACOLOGY (2009)
The thioredoxin system in cancer
Elias S. J. Arner et al.
SEMINARS IN CANCER BIOLOGY (2006)
High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer
SJ Kim et al.
CLINICAL CANCER RESEARCH (2005)
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3
D Chendil et al.
ONCOGENE (2004)
Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H: quinone oxidoreductase 1, in cellular systems
DL Dehn et al.
MOLECULAR PHARMACOLOGY (2003)
分享论文
